EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Alcohol‐Associated Liver Disease: Epidemiology, Pathogenesis, and Emerging Therapeutic Targets

Shuyan Wang, Yirui Hu, Huikuan Chu

MedComm · 2026-11 · 7 (11)

DOI: 10.1002/mco2.71120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 05.11.2026. Verfasst von Shuyan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China. Die Arbeit nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alcohol‐associated liver disease (ALD) represents a leading cause of preventable liver‐related morbidity and mortality worldwide. Despite its growing global burden, no pharmacological therapies targeting disease progression have achieved clinical approval, with management still centered on alcohol abstinence and supportive care. Classic pathogenic mechanisms, including ethanol metabolism, oxidative stress, innate immune activation, and regulated cell death, are well recognized, yet emerging evidence highlights the gut–liver axis and intestinal dysbiosis as critical, interactive drivers of disease pathophysiology. However, how gut microbial imbalance mechanistically intersects with these canonical pathways to accelerate ALD progression remains insufficiently integrated. This article summarizes the epidemiology, clinical manifestations, and pathogenesis of ALD. Importantly, we focus specifically on changes in the gut microbiota (including bacteria, fungi, and viruses) and microbial metabolites. We further discuss the interactive relationships between dysbiosis and these core mechanisms. Finally, we summarize progress in preclinical and clinical research on targeted strategies such as probiotics, fecal microbiota transplantation, and phage therapy. By synthesizing the research findings, we propose a stage‐based, mechanism‐oriented framework aimed at advancing the development of safer and more precise therapeutic interventions for ALD.

Schlagwörter

Stichwörter der Autor:innen

alcohol‐associated liver diseasecell deathepidemiologygut–liver axisinflammationmicrobiotatherapeutic targets

Autor:innen und Institutionen

  • Division of Gastroenterology, Union Hospital, Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, S., Hu, Y., & Chu, H. (2026). Alcohol‐Associated Liver Disease: Epidemiology, Pathogenesis, and Emerging Therapeutic Targets. MedComm, 7(11). https://doi.org/10.1002/mco2.71120

Vancouver

Wang S, Hu Y, Chu H. Alcohol‐Associated Liver Disease: Epidemiology, Pathogenesis, and Emerging Therapeutic Targets. MedComm. 2026;7(11). doi:10.1002/mco2.71120

BibTeX
@article{Wang2026,
  author = {Wang, Shuyan and Hu, Yirui and Chu, Huikuan},
  title = {Alcohol‐Associated Liver Disease: Epidemiology, Pathogenesis, and Emerging Therapeutic Targets},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {11},
  doi = {10.1002/mco2.71120}
}
Kostenlos starten →